Currency in INR
| Earnings estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
|---|
| No. of analysts | 0 | 0 | 0 | 0 |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low estimate | 0 | 0 | 0 | 0 |
| High estimate | 0 | 0 | 0 | 0 |
| Year ago EPS | N/A | N/A | N/A | N/A |
| Revenue estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
|---|
| No. of analysts | 0 | 0 | 4 | 4 |
| Avg. Estimate | N/A | N/A | 14.49B | 16.65B |
| Low estimate | N/A | N/A | 13.92B | 15.83B |
| High estimate | N/A | N/A | 15.3B | 18.3B |
| Year ago sales | N/A | N/A | 12.44B | 14.49B |
| Sales growth (year/est) | N/A | N/A | 16.50% | 14.90% |
| Earnings history | Invalid Date | Invalid Date | 30/06/2017 | 30/09/2018 |
|---|
| Est. EPS | N/A | N/A | 9.35 | 11.67 |
| Actual EPS | N/A | N/A | 4.77 | 7.65 |
| Difference | N/A | N/A | -4.58 | -4.02 |
| Surprise % | N/A | N/A | -49.00% | -34.40% |
| EPS trend | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
|---|
| Current estimate | 0 | 0 | 0 | 0 |
| 7 days ago | 0 | 0 | 38.66 | 49.14 |
| 30 days ago | 0 | 0 | 38.66 | 49.14 |
| 60 days ago | 0 | 0 | 38.66 | 49.14 |
| 90 days ago | 0 | 0 | 38.66 | 49.14 |
| EPS revisions | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | AARTIDRUGS.BO | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | N/A | N/A | N/A | N/A |
| Next year | N/A | N/A | N/A | N/A |
| Next 5 years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |
